Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 139

1.

Keratin 18 is an integral part of the intermediate filament network in murine skeletal muscle.

Muriel JM, O'Neill A, Kerr JP, Kleinhans-Welte E, Lovering RM, Bloch RJ.

Am J Physiol Cell Physiol. 2020 Jan 1;318(1):C215-C224. doi: 10.1152/ajpcell.00279.2019. Epub 2019 Nov 13.

PMID:
31721615
2.

Skeletal muscle cell transplantation: models and methods.

Mueller AL, Bloch RJ.

J Muscle Res Cell Motil. 2019 Aug 7. doi: 10.1007/s10974-019-09550-w. [Epub ahead of print]

PMID:
31392564
3.

Muscle xenografts reproduce key molecular features of facioscapulohumeral muscular dystrophy.

Mueller AL, O'Neill A, Jones TI, Llach A, Rojas LA, Sakellariou P, Stadler G, Wright WE, Eyerman D, Jones PL, Bloch RJ.

Exp Neurol. 2019 Oct;320:113011. doi: 10.1016/j.expneurol.2019.113011. Epub 2019 Jul 12.

PMID:
31306642
4.

Effect of Ibuprofen on Skeletal Muscle of Dysferlin-Null Mice.

Collier AF, Gumerson J, Lehtimäki K, Puoliväli J, Jones JW, Kane MA, Manne S, O'Neill A, Windish HP, Ahtoniemi T, Williams BA, Albrecht DE, Bloch RJ.

J Pharmacol Exp Ther. 2018 Mar;364(3):409-419. doi: 10.1124/jpet.117.244244. Epub 2017 Dec 28.

5.

Absence of synemin in mice causes structural and functional abnormalities in heart.

García-Pelagio KP, Chen L, Joca HC, Ward C, Jonathan Lederer W, Bloch RJ.

J Mol Cell Cardiol. 2018 Jan;114:354-363. doi: 10.1016/j.yjmcc.2017.12.005. Epub 2017 Dec 14.

6.

Coupling of excitation to Ca2+ release is modulated by dysferlin.

Lukyanenko V, Muriel JM, Bloch RJ.

J Physiol. 2017 Aug 1;595(15):5191-5207. doi: 10.1113/JP274515. Epub 2017 Jun 26.

7.

Interactions between small ankyrin 1 and sarcolipin coordinately regulate activity of the sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA1).

Desmond PF, Labuza A, Muriel J, Markwardt ML, Mancini AE, Rizzo MA, Bloch RJ.

J Biol Chem. 2017 Jun 30;292(26):10961-10972. doi: 10.1074/jbc.M117.783613. Epub 2017 May 9.

8.

Deficiency of the intermediate filament synemin reduces bone mass in vivo.

Moorer MC, Buo AM, Garcia-Pelagio KP, Stains JP, Bloch RJ.

Am J Physiol Cell Physiol. 2016 Dec 1;311(6):C839-C845. doi: 10.1152/ajpcell.00218.2016. Epub 2016 Sep 7.

9.

Neuromuscular electrical stimulation promotes development in mice of mature human muscle from immortalized human myoblasts.

Sakellariou P, O'Neill A, Mueller AL, Stadler G, Wright WE, Roche JA, Bloch RJ.

Skelet Muscle. 2016 Feb 27;6:4. doi: 10.1186/s13395-016-0078-6. eCollection 2016.

10.

Identification of Small Ankyrin 1 as a Novel Sarco(endo)plasmic Reticulum Ca2+-ATPase 1 (SERCA1) Regulatory Protein in Skeletal Muscle.

Desmond PF, Muriel J, Markwardt ML, Rizzo MA, Bloch RJ.

J Biol Chem. 2015 Nov 13;290(46):27854-67. doi: 10.1074/jbc.M115.676585. Epub 2015 Sep 24.

11.

Myofiber damage precedes macrophage infiltration after in vivo injury in dysferlin-deficient A/J mouse skeletal muscle.

Roche JA, Tulapurkar ME, Mueller AL, van Rooijen N, Hasday JD, Lovering RM, Bloch RJ.

Am J Pathol. 2015 Jun;185(6):1686-98. doi: 10.1016/j.ajpath.2015.02.020. Epub 2015 Apr 25.

12.

Myopathic changes in murine skeletal muscle lacking synemin.

García-Pelagio KP, Muriel J, O'Neill A, Desmond PF, Lovering RM, Lund L, Bond M, Bloch RJ.

Am J Physiol Cell Physiol. 2015 Mar 15;308(6):C448-62. doi: 10.1152/ajpcell.00331.2014. Epub 2015 Jan 7.

13.

Muscle structure influences utrophin expression in mdx mice.

Banks GB, Combs AC, Odom GL, Bloch RJ, Chamberlain JS.

PLoS Genet. 2014 Jun 12;10(6):e1004431. doi: 10.1371/journal.pgen.1004431. eCollection 2014 Jun.

14.

Dysferlin at transverse tubules regulates Ca(2+) homeostasis in skeletal muscle.

Kerr JP, Ward CW, Bloch RJ.

Front Physiol. 2014 Mar 6;5:89. doi: 10.3389/fphys.2014.00089. eCollection 2014. Review.

15.

Dysferlin stabilizes stress-induced Ca2+ signaling in the transverse tubule membrane.

Kerr JP, Ziman AP, Mueller AL, Muriel JM, Kleinhans-Welte E, Gumerson JD, Vogel SS, Ward CW, Roche JA, Bloch RJ.

Proc Natl Acad Sci U S A. 2013 Dec 17;110(51):20831-6. doi: 10.1073/pnas.1307960110. Epub 2013 Dec 3.

16.

Lack of correlation between outcomes of membrane repair assay and correction of dystrophic changes in experimental therapeutic strategy in dysferlinopathy.

Lostal W, Bartoli M, Roudaut C, Bourg N, Krahn M, Pryadkina M, Borel P, Suel L, Roche JA, Stockholm D, Bloch RJ, Levy N, Bashir R, Richard I.

PLoS One. 2012;7(5):e38036. doi: 10.1371/journal.pone.0038036. Epub 2012 May 29.

17.

Structural and functional evaluation of branched myofibers lacking intermediate filaments.

Goodall MH, Ward CW, Pratt SJP, Bloch RJ, Lovering RM.

Am J Physiol Cell Physiol. 2012 Jul 15;303(2):C224-32. doi: 10.1152/ajpcell.00136.2012. Epub 2012 May 16.

18.

Optimization of large gel 2D electrophoresis for proteomic studies of skeletal muscle.

Reed PW, Densmore A, Bloch RJ.

Electrophoresis. 2012 Apr;33(8):1263-70. doi: 10.1002/elps.201100642.

19.

Muscle contractility and cell motility.

Jin JP, Bloch RJ, Huang X, Larsson L.

J Biomed Biotechnol. 2012;2012:257812. doi: 10.1155/2012/257812. Epub 2012 Feb 24. No abstract available.

20.

Distinct effects of contraction-induced injury in vivo on four different murine models of dysferlinopathy.

Roche JA, Ru LW, Bloch RJ.

J Biomed Biotechnol. 2012;2012:134031. doi: 10.1155/2012/134031. Epub 2012 Feb 6.

21.

Hydrophobic residues in small ankyrin 1 participate in binding to obscurin.

Willis CD, Oashi T, Busby B, Mackerell AD Jr, Bloch RJ.

Mol Membr Biol. 2012 Mar;29(2):36-51. doi: 10.3109/09687688.2012.660709.

22.

Influences of desmin and keratin 19 on passive biomechanical properties of mouse skeletal muscle.

Shah SB, Love JM, O'Neill A, Lovering RM, Bloch RJ.

J Biomed Biotechnol. 2012;2012:704061. doi: 10.1155/2012/704061. Epub 2012 Jan 4.

23.

Integrity of the network sarcoplasmic reticulum in skeletal muscle requires small ankyrin 1.

Ackermann MA, Ziman AP, Strong J, Zhang Y, Hartford AK, Ward CW, Randall WR, Kontrogianni-Konstantopoulos A, Bloch RJ.

J Cell Sci. 2011 Nov 1;124(Pt 21):3619-30. doi: 10.1242/jcs.085159. Epub 2011 Nov 1.

24.

Unmasking potential intracellular roles for dysferlin through improved immunolabeling methods.

Roche JA, Ru LW, O'Neill AM, Resneck WG, Lovering RM, Bloch RJ.

J Histochem Cytochem. 2011 Nov;59(11):964-75. doi: 10.1369/0022155411423274.

25.

Synemin isoforms differentially organize cell junctions and desmin filaments in neonatal cardiomyocytes.

Lund LM, Kerr JP, Lupinetti J, Zhang Y, Russell MA, Bloch RJ, Bond M.

FASEB J. 2012 Jan;26(1):137-48. doi: 10.1096/fj.10-179408. Epub 2011 Oct 7.

26.

Determinants of the repeated-bout effect after lengthening contractions.

Dipasquale DM, Bloch RJ, Lovering RM.

Am J Phys Med Rehabil. 2011 Oct;90(10):816-24. doi: 10.1097/PHM.0b013e3182240b30. Erratum in: Am J Phys Med Rehabil. 2012 Apr;91(4):308.

27.

Physiological and histological changes in skeletal muscle following in vivo gene transfer by electroporation.

Roche JA, Ford-Speelman DL, Ru LW, Densmore AL, Roche R, Reed PW, Bloch RJ.

Am J Physiol Cell Physiol. 2011 Nov;301(5):C1239-50. doi: 10.1152/ajpcell.00431.2010. Epub 2011 Aug 10.

28.

Crystallin-gazing: unveiling enzymatic activity.

Reed PW, Bloch RJ.

J Neurochem. 2011 Aug;118(3):315-6. doi: 10.1111/j.1471-4159.2011.07249.x. No abstract available.

29.

Electrostatic interactions mediate binding of obscurin to small ankyrin 1: biochemical and molecular modeling studies.

Busby B, Oashi T, Willis CD, Ackermann MA, Kontrogianni-Konstantopoulos A, Mackerell AD Jr, Bloch RJ.

J Mol Biol. 2011 Apr 29;408(2):321-34. doi: 10.1016/j.jmb.2011.01.053. Epub 2011 Feb 17.

30.

Biomechanics of the sarcolemma and costameres in single skeletal muscle fibers from normal and dystrophin-null mice.

García-Pelagio KP, Bloch RJ, Ortega A, González-Serratos H.

J Muscle Res Cell Motil. 2011 Mar;31(5-6):323-36. doi: 10.1007/s10974-011-9238-9. Epub 2011 Feb 11.

31.

The actin binding domain of βI-spectrin regulates the morphological and functional dynamics of dendritic spines.

Nestor MW, Cai X, Stone MR, Bloch RJ, Thompson SM.

PLoS One. 2011 Jan 31;6(1):e16197. doi: 10.1371/journal.pone.0016197.

32.

Physiology, structure, and susceptibility to injury of skeletal muscle in mice lacking keratin 19-based and desmin-based intermediate filaments.

Lovering RM, O'Neill A, Muriel JM, Prosser BL, Strong J, Bloch RJ.

Am J Physiol Cell Physiol. 2011 Apr;300(4):C803-13. doi: 10.1152/ajpcell.00394.2010. Epub 2011 Jan 5.

33.

Effects of the plasmid-encoded toxin of enteroaggregative Escherichia coli on focal adhesion complexes.

Cappello RE, Estrada-Gutierrez G, Irles C, Giono-Cerezo S, Bloch RJ, Nataro JP.

FEMS Immunol Med Microbiol. 2011 Apr;61(3):301-14. doi: 10.1111/j.1574-695X.2010.00776.x. Epub 2011 Feb 7.

34.

Quantitative measurement of Ca²(+) in the sarcoplasmic reticulum lumen of mammalian skeletal muscle.

Ziman AP, Ward CW, Rodney GG, Lederer WJ, Bloch RJ.

Biophys J. 2010 Oct 20;99(8):2705-14. doi: 10.1016/j.bpj.2010.08.032.

35.

Characterization and comparison of two binding sites on obscurin for small ankyrin 1.

Busby B, Willis CD, Ackermann MA, Kontrogianni-Konstantopoulos A, Bloch RJ.

Biochemistry. 2010 Nov 23;49(46):9948-56. doi: 10.1021/bi101165p. Epub 2010 Nov 1.

36.

Cooperativity between the phosphorylation of Thr95 and Ser77 of NHERF-1 in the hormonal regulation of renal phosphate transport.

Weinman EJ, Steplock D, Zhang Y, Biswas R, Bloch RJ, Shenolikar S.

J Biol Chem. 2010 Aug 13;285(33):25134-8. doi: 10.1074/jbc.M110.132423. Epub 2010 Jun 22.

37.

Characterization and expression of a heart-selective alternatively spliced variant of alpha II-spectrin, cardi+, during development in the rat.

Zhang Y, Resneck WG, Lee PC, Randall WR, Bloch RJ, Ursitti JA.

J Mol Cell Cardiol. 2010 Jun;48(6):1050-9. doi: 10.1016/j.yjmcc.2010.01.001. Epub 2010 Jan 28.

38.

Extensive mononuclear infiltration and myogenesis characterize recovery of dysferlin-null skeletal muscle from contraction-induced injuries.

Roche JA, Lovering RM, Roche R, Ru LW, Reed PW, Bloch RJ.

Am J Physiol Cell Physiol. 2010 Feb;298(2):C298-312. doi: 10.1152/ajpcell.00122.2009. Epub 2009 Nov 18.

39.

Genetic manipulation of dysferlin expression in skeletal muscle: novel insights into muscular dystrophy.

Millay DP, Maillet M, Roche JA, Sargent MA, McNally EM, Bloch RJ, Molkentin JD.

Am J Pathol. 2009 Nov;175(5):1817-23. doi: 10.2353/ajpath.2009.090107. Epub 2009 Oct 15.

40.

Excitation-contraction coupling changes during postnatal cardiac development.

Ziman AP, Gómez-Viquez NL, Bloch RJ, Lederer WJ.

J Mol Cell Cardiol. 2010 Feb;48(2):379-86. doi: 10.1016/j.yjmcc.2009.09.016. Epub 2009 Oct 8.

41.

Muscle giants: molecular scaffolds in sarcomerogenesis.

Kontrogianni-Konstantopoulos A, Ackermann MA, Bowman AL, Yap SV, Bloch RJ.

Physiol Rev. 2009 Oct;89(4):1217-67. doi: 10.1152/physrev.00017.2009. Review.

42.

The rho-guanine nucleotide exchange factor domain of obscurin activates rhoA signaling in skeletal muscle.

Ford-Speelman DL, Roche JA, Bowman AL, Bloch RJ.

Mol Biol Cell. 2009 Sep;20(17):3905-17. doi: 10.1091/mbc.E08-10-1029. Epub 2009 Jul 15.

43.

Gait analysis of locomotory impairment in rats before and after neuromuscular injury.

Tang W, Lovering RM, Roche JA, Bloch RJ, Neerchal NK, Tasch U.

J Neurosci Methods. 2009 Jul 30;181(2):249-56. doi: 10.1016/j.jneumeth.2009.04.027. Epub 2009 May 9.

44.

Obscurin interacts with a novel isoform of MyBP-C slow at the periphery of the sarcomeric M-band and regulates thick filament assembly.

Ackermann MA, Hu LY, Bowman AL, Bloch RJ, Kontrogianni-Konstantopoulos A.

Mol Biol Cell. 2009 Jun;20(12):2963-78. doi: 10.1091/mbc.E08-12-1251. Epub 2009 Apr 29.

45.

Impaired recovery of dysferlin-null skeletal muscle after contraction-induced injury in vivo.

Roche JA, Lovering RM, Bloch RJ.

Neuroreport. 2008 Oct 29;19(16):1579-84. doi: 10.1097/WNR.0b013e328311ca35.

46.

The rho-guanine nucleotide exchange factor domain of obscurin regulates assembly of titin at the Z-disk through interactions with Ran binding protein 9.

Bowman AL, Catino DH, Strong JC, Randall WR, Kontrogianni-Konstantopoulos A, Bloch RJ.

Mol Biol Cell. 2008 Sep;19(9):3782-92. doi: 10.1091/mbc.E08-03-0237. Epub 2008 Jun 25.

47.

Absence of keratin 19 in mice causes skeletal myopathy with mitochondrial and sarcolemmal reorganization.

Stone MR, O'Neill A, Lovering RM, Strong J, Resneck WG, Reed PW, Toivola DM, Ursitti JA, Omary MB, Bloch RJ.

J Cell Sci. 2007 Nov 15;120(Pt 22):3999-4008. Epub 2007 Oct 30.

48.

Mapping the binding site on small ankyrin 1 for obscurin.

Borzok MA, Catino DH, Nicholson JD, Kontrogianni-Konstantopoulos A, Bloch RJ.

J Biol Chem. 2007 Nov 2;282(44):32384-96. Epub 2007 Aug 25.

49.

Identification of skeletal muscle mutations in tail snips from neonatal mice using immunohistochemistry.

Lovering RM, O'Neill A, Roche JA, Bloch RJ.

Biotechniques. 2007 Jun;42(6):702, 704. No abstract available.

50.

Muscle intermediate filaments and their links to membranes and membranous organelles.

Capetanaki Y, Bloch RJ, Kouloumenta A, Mavroidis M, Psarras S.

Exp Cell Res. 2007 Jun 10;313(10):2063-76. Epub 2007 Apr 3. Review.

PMID:
17509566

Supplemental Content

Loading ...
Support Center